CRX.L Regulatory News (CRX)

14 Aug 2007 07:00

Cyprotex PLC14 August 2007 Cyprotex PLC ("Cyprotex" or "the Company") Cyprotex PLC (AIM:CRX), the drug discovery technology and information company,today announces that it has issued 10,398 new ordinary shares of 0.1p each ("newOrdinary Shares") pursuant to the exercise of options. The issue of these new Ordinary shares is subject to the new Ordinary Sharesbeing admitted to trading on AIM, application for which has been made. Tradingin the new Ordinary Shares, which will rank pari passu in all respects with theexisting ordinary shares, is expected to commence on 15 August 2007. - Ends - For further information: Cyprotex PLCRobert Morrisson Atwater Tel: +44 (0) 1625 505100Chairman & Chief Executive OfficerRussell GibbsChief Financial Officeriir@cyprotex.com www.cyprotex.com This information is provided by RNS The company news service from the London Stock Exchange